“…The prevalence of qacA/B in S. aureus reported over the last decade is very variable although the drivers for high carriage are not clear. While some studies continue to report declining susceptibility to chlorhexidine and increasing prevalence of qacA/B in MRSA from a range of clinical settings 8,9 , other studies, including our own work, report low presence of qacA/B in S. aureus from screening samples and bacteraemia patients 10,11 . However, we have shown a high prevalence (80%) of qacA/B in S. epidermidis isolates from blood cultures randomly collected over 6 years in an intensive care unit in Scotland, with qacA/B carriage coinciding with reduced susceptibility to chlorhexidine 11 .…”